VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Science Officer | Oct 25, 2016 | Option Exercise | $21.00 | 228,274 | 4,793,754 | 228,274 | Oct 25, 2016, 04:43 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gunderson Robert V JR | Director | Oct 24, 2016 | Option Exercise | $21.00 | 15,830 | 332,430 | 0 | Oct 25, 2016, 04:34 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gunderson Robert V JR | Director | Oct 24, 2016 | Option Exercise | $21.00 | 11,002 | 231,042 | 0 | Oct 25, 2016, 04:34 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Oct 24, 2016 | Option Exercise | $21.00 | 244,996 | 5,144,916 | 244,996 | Oct 25, 2016, 04:33 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Fratamico Arthur | Chief Business Officer | Oct 24, 2016 | Option Exercise | $21.00 | 13,233 | 277,893 | 0 | Oct 25, 2016, 04:32 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Morris Richard Steven | Chief Financial Officer | Oct 25, 2016 | Option Exercise | $21.00 | 828 | 17,388 | 0 | Oct 25, 2016, 04:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Science Officer | Oct 19, 2016 | Option Exercise | $5.27 | 123,902 | 652,795 | 228,274 | Oct 21, 2016, 05:00 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Sep 14, 2016 | Sale | $20.81 | 50,000 | 1,040,500 | 244,996 | Sep 16, 2016, 05:00 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Atchinson Robert | 10% Owner | Sep 14, 2016 | Sale | $20.85 | 1,025,000 | 21,371,250 | 2,375,000 | Sep 16, 2016, 04:03 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Fratamico Arthur | Chief Business Officer | Apr 29, 2016 | Option Exercise | $6.11 | 2,086 | 12,745 | 12,086 | Aug 17, 2016, 05:09 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Science Officer | Apr 29, 2016 | Option Exercise | $6.11 | 2,100 | 12,831 | 104,372 | Aug 17, 2016, 05:09 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Morris Richard Steven | Chief Financial Officer | Apr 29, 2016 | Option Exercise | $6.11 | 828 | 5,059 | 828 | Aug 17, 2016, 05:08 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Apr 29, 2016 | Option Exercise | $6.11 | 747 | 4,564 | 294,996 | Aug 17, 2016, 05:08 PM |
VTAE | | Vitae Pharmaceuticals, Inc | HAYDEN DONALD J JR | Director | Mar 21, 2016 | Sale | $5.44 | 32,260 | 175,333 | 14,195 | Mar 21, 2016, 09:32 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Scientific Officer | Nov 16, 2015 | Option Exercise | $3.91 | 15,000 | 58,650 | 102,272 | Jan 25, 2016, 05:04 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Dec 28, 2015 | Option Exercise | $3.45 | 26,537 | 91,553 | 294,249 | Jan 25, 2016, 05:02 PM |
VTAE | | Vitae Pharmaceuticals, Inc | HAYDEN DONALD J JR | Director | Dec 29, 2015 | Sale | $10.73 | 32,260 | 345,989 | 16,130 | Dec 30, 2015, 05:57 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Dec 28, 2015 | Option Exercise | $3.45 | 26,537 | 91,553 | 293,897 | Dec 28, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Dec 23, 2015 | Option Exercise | $10.23 | 45,048 | 460,616 | 289,884 | Dec 28, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Science Officer | Nov 16, 2015 | Option Exercise | $3.91 | 15,000 | 58,650 | 100,557 | Nov 17, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Gregg Richard | Chief Science Officer | Nov 13, 2015 | Option Exercise | $4.15 | 85,557 | 354,779 | 85,557 | Nov 17, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | HAYDEN DONALD J JR | Director | Sep 21, 2015 | Option Exercise | $10.23 | 32,260 | 329,859 | 16,130 | Sep 22, 2015, 05:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Fratamico Arthur | Chief Business Officer | Aug 27, 2015 | Buy | $7.83 | 10,000 | 78,266 | 10,000 | Aug 31, 2015, 04:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | HAYDEN DONALD J JR | Director | May 20, 2015 | Option Exercise | $7.73 | 40,000 | 309,200 | 20,000 | May 22, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Mar 13, 2015 | Option Exercise | $11.16 | 171,156 | 1,910,101 | 267,360 | Mar 17, 2015, 04:30 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Mar 06, 2015 | Option Exercise | $1.15 | 8,115 | 9,332 | 438,516 | Mar 09, 2015, 05:05 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Hatfield Jeffrey S. | Chief Executive Officer | Jan 22, 2015 | Option Exercise | $1.15 | 39,097 | 44,962 | 430,401 | Jan 26, 2015, 04:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | PROSPECT VENTURE PARTNERS II LP | 10% Owner | Sep 29, 2014 | Buy | $8.00 | 671,807 | 5,374,456 | 2,572,523 | Oct 01, 2014, 09:03 PM |
VTAE | | Vitae Pharmaceuticals, Inc | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Sep 29, 2014 | Buy | $8.00 | 4,067,370 | 32,538,960 | 2,611,564 | Oct 01, 2014, 04:36 PM |
VTAE | | Vitae Pharmaceuticals, Inc | ROBERTS BRYAN E | Director | Sep 29, 2014 | Buy | $8.00 | 772,333 | 6,178,664 | 1,883,372 | Oct 01, 2014, 04:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | Barrett Peter | Director | Sep 29, 2014 | Buy | $8.00 | 37,500 | 300,000 | 1,174,315 | Oct 01, 2014, 04:31 PM |
VTAE | | Vitae Pharmaceuticals, Inc | VENROCK MANAGEMENT III LLC | 10% Owner | Sep 29, 2014 | Buy | $8.00 | 3,861,665 | 30,893,320 | 1,883,372 | Oct 01, 2014, 04:31 PM |